12 Most Expensive Stocks Insiders Are Buying After Trump’s Tariff Rollout

3. Nutex Health Inc. (NASDAQ:NUTX)

Nutex Health is a physician-led healthcare services and operations company based in Houston, Texas. It operates through three segments: Hospital, Population Health Management, and Real Estate, offering services like 24/7 emergency and inpatient care, imaging, labs, and pharmacy support. The company also manages physician groups, runs a cloud-based healthcare platform, and owns hospital properties across the U.S.

On April 8, the company’s CFO Christian Jon Bates purchased around $81,810 worth of Nutex Health shares at an average price of $81.81 per share. Year-to-date, the stock gained 370.18% and is now trading at $149 per share. Over the past 12 months, Nutex Health returned 2,962.55% to its investors.

For the year ended December 31, 2024, Nutex Health reported total revenue of $479.9 million, up 93.8% from 2023, driven largely by $169.7 million in arbitration-related revenue. The company achieved $130.6 million in operating income, a major turnaround from a $31.8 million loss the previous year, and posted net income of $52.2 million. Adjusted EBITDA soared to $123.7 million, up over 1,000% year-over-year, with hospital visits rising nearly 17% to 168,388.

Nutex Health is also one of the 12 best performing small cap stocks so far in 2025.